Clinical Biochemistry

Papers
(The H4-Index of Clinical Biochemistry is 20. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2020-05-01 to 2024-05-01.)
ArticleCitations
After another decade: LC–MS/MS became routine in clinical diagnostics165
Laboratory abnormalities in children with mild and severe coronavirus disease 2019 (COVID-19): A pooled analysis and review108
CRISPR-based tools: Alternative methods for the diagnosis of COVID-1968
Are antioxidant enzymes essential markers in the diagnosis and monitoring of cancer patients – A review64
Roles of matrix metalloproteinase-7 (MMP-7) in cancer64
Shrunken pore syndrome - a common kidney disorder with high mortality. Diagnosis, prevalence, pathophysiology and treatment options46
The application of fully automated dried blood spot analysis for liquid chromatography-tandem mass spectrometry using the CAMAG DBS-MS 500 autosampler38
Diagnostic value of serum glypican-3 alone and in combination with AFP as an aid in the diagnosis of liver cancer36
Real-world big-data studies in laboratory medicine: Current status, application, and future considerations32
OMICS insights into cancer histology; Metabolomics and proteomics approach30
Current use of bone turnover markers in the management of osteoporosis29
Applications of machine learning in routine laboratory medicine: Current state and future directions28
Advancements in the gold standard: Measuring steroid sex hormones by mass spectrometry27
Genetic signature of CTLA-4, BTLA, TIM-3 and LAG-3 molecular expression in colorectal cancer patients: Implications in diagnosis and survival outcomes26
Uncarboxylated matrix Gla-protein: A biomarker of vitamin K status and cardiovascular risk24
Discovery and comparison of serum biomarkers for diabetes mellitus and metabolic syndrome based on UPLC-Q-TOF/MS23
A novel, mitochondrial, internal tRNA-derived RNA fragment possesses clinical utility as a molecular prognostic biomarker in chronic lymphocytic leukemia22
High clinical performance and quantitative assessment of antibody kinetics using a dual recognition assay for the detection of SARS-CoV-2 IgM and IgG antibodies21
Early prediction of COVID-19-associated acute kidney injury: Are serum NGAL and serum Cystatin C levels better than serum creatinine?20
Effects of fetuin-A with diverse functions and multiple mechanisms on human health20
0.03088903427124